BIBLIOGRAPHIC RECORD
Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Jamie E. Chaft; Geoffrey R. Oxnard; Camelia S. Sima; Mark G. Kris; Vincent A. Miller; Gregory J. Riely
- Source of metadata
- OpenAlex
- Year recorded
- 2011
Public identifiers and source
Open the source recordReference
Jamie E. Chaft; Geoffrey R. Oxnard; Camelia S. Sima; Mark G. Kris; Vincent A. Miller; Gregory J. Riely. (2011). Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design. https://openalex.org/W2128208856
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-8ce79cfce824491b84e9ce08b4c1beec/